Innocoll Holdings PLC (NASDAQ:INNL) has been given an average broker rating score of 0.00 () from the five analysts that provide coverage for the stock, Zacks Investment Research reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company.

Brokers have set a 1-year consensus price target of $4.50 for the company, according to Zacks. Zacks has also assigned Innocoll Holdings PLC an industry rank of 96 out of 265 based on the ratings given to its competitors.

A number of equities research analysts recently weighed in on INNL shares. FBR & Co cut Innocoll Holdings PLC from an “outperform” rating to a “market perform” rating and upped their price objective for the stock from $2.00 to $10.00 in a research note on Friday, December 30th. Janney Montgomery Scott cut Innocoll Holdings PLC from a “buy” rating to a “neutral” rating and set a $2.00 price objective for the company. in a research note on Friday, December 30th. Zacks Investment Research cut Innocoll Holdings PLC from a “buy” rating to a “hold” rating in a research note on Wednesday, March 1st. Stifel Nicolaus lowered Innocoll Holdings PLC from a “buy” rating to a “hold” rating and reduced their target price for the company from $9.00 to $2.00 in a research report on Friday. Finally, JMP Securities lowered Innocoll Holdings PLC from an “outperform” rating to a “market perform” rating in a research report on Friday, December 30th.

A hedge fund recently raised its stake in Innocoll Holdings PLC stock. Alyeska Investment Group L.P. raised its stake in shares of Innocoll Holdings PLC (NASDAQ:INNL) by 57.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 837,626 shares of the specialty pharmaceutical company’s stock after buying an additional 305,482 shares during the period. Alyeska Investment Group L.P. owned about 2.82% of Innocoll Holdings PLC worth $578,000 as of its most recent filing with the SEC. 42.88% of the stock is currently owned by institutional investors.

Innocoll Holdings PLC (NASDAQ:INNL) opened at 1.12 on Tuesday. The stock’s 50 day moving average price is $0.78 and its 200-day moving average price is $2.97. Innocoll Holdings PLC has a 52-week low of $0.53 and a 52-week high of $12.94. The stock’s market capitalization is $33.26 million.

Your IP Address:

About Innocoll Holdings PLC

Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.

5 Day Chart for NASDAQ:INNL

Get a free copy of the Zacks research report on Innocoll Holdings PLC (INNL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.